SynBiotic SE

Recommendation

Buy

Price Target

€12.40

Upside

288.71%

Chart
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 3Y

€3.19

€0.08 (2.57%)
Realtime-Data from 23.04.2025 15:52:35
SYNBIOTIC is a Buy-and-Build operator in the European industrial hemp, cannabis and cannabinoid market with an objective to establish a fully integrated platform-company with activities across the entire value chain from cultivation to production and retail.
Ticker
SBX GY
Market Cap
€17.86 M
Enterprise Value
€20.94 M
26 week avg vol.
13500
Primar Exchange
Xetra
IPO
2019
Sector
Health Care & Pharma
Headquarters
München, DE
Employees
55
Incorporated
2015
CEO
Daniel Kruse
CEO
7.62%
Other institutional investors
47.00%
Free Float
45.38%
20.09.2024
Annual General Meeting
30.09.2024
Publication half yearly financial report

KPIs in EUR

KPI20232024e2025e
Sales3.86 M15.92 M22.99 M
EBITDA(7.19 M)(1.01 M)1.84 M
EBIT(11.75 M)(2.13 M)756.62 K
EPS(2.12)(0.30)0.06
FCF(2.94 M)(4.33 M)1.35 M

Valuation

KPI20232024e2025e
EV / Sales5.42x1.30x0.84x
EV / EBITDA(2.91x)(20.38x)10.52x
EV / EBIT(1.78x)(9.71x)25.52x
Price / Earnings(1.50x)(10.48x)52.81x
EV / FCF(7.11x)(4.77x)14.27x

Best-in-class research on selected German and European small caps. Immediately at publication and 100% free of charge.

To learn how we process your data, visit our Privacy Notice.